Clinical trial

Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of…

NCT00383500 · Stanford University, Other · Completed

Key facts

NCT number NCT00383500
Title Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Official title To Prospectively Evaluate the Potential for Simple, Effective Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Lead sponsor Stanford University, Other
Status Completed
Study type Interventional
Conditions Lymphedema, Breast Cancer
Intervention type Device
Interventions Flexitouch, Class 1 compression garment
Enrollment 75
Start date May 1, 2005
Primary completion Jul 1, 2009
Completion Sep 1, 2009
First posted Oct 3, 2006
Last update posted Mar 30, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies